Immune Drugs - Global and China Top Players Market Share and Ranking 2024

Report Code : AMP2755973
Published On: Jul, 2024
Category : Healthcare & Pharma
Pages : 151

According to Ample Market Research, the global market for Immune Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
This report studies and analyses global Immune Drugs status and future trends, helps the client to determine the Immune Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Immune Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Immune Drugs market size, history data 2019-2024, and forecast data 2024 -2030, (US$ million) & (K Units)
(2) Global Immune Drugs sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(3) China Immune Drugs sales, revenue, price by company, market share and industry ranking 2019-2024, (US$ million) & (K Units)
(4) Global Immune Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Immune Drugs key producing regions, capacity, production, and year over year growth
(6) Immune Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Antares Pharma, Inc.
UCB
Incyte
GSK
Takeda
3S Bio
Horizon Therapeutics
Bristol-Myers Squibb (BMS
Astellas
Eli Lilly
Mitsubishi Tanabe Pharma
Biogen
Pfizer
Sanofi
Roche
Novartis
Johnson & Johnson (J&J)
Amgen
Abbvi
Market segment by Type, covers
Immune Boosting Drugs
Immunosuppressant Drugs
Market segment by Application, can be divided into
Hospital
Clinic
Surgery Center
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Immune Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Immune Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 3: China Immune Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2019-2024
Chapter 4: Global key producing regions of Immune Drugs, percent & CAGR, 2019-2030
Chapter 5: Immune Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2019-2030
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
With tables and figures helping analyze worldwide Immune Drugs Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

1 Market Overview
1.1 Immune Drugs Definition
1.2 Global Immune Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Immune Drugs Market Size，2019-2030
1.2.2 By Sales Quantity, Global Immune Drugs Market Size，2019-2030
1.2.3 Global Immune Drugs Average Selling Price (ASP)，2019-2030
1.3 China Immune Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Immune Drugs Market Size，2019-2030
1.3.2 By Sales Quantity, China Immune Drugs Market Size，2019-2030
1.3.3 China Immune Drugs Average Selling Price (ASP)， 2019-2030
1.4 Share of China Immune Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Immune Drugs Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Immune Drugs Market Share in Global, 2019-2030
1.4.3 Immune Drugs Market Size: China VS Global, 2019-2030
1.5 Immune Drugs Market Dynamics
1.5.1 Immune Drugs Market Drivers
1.5.2 Immune Drugs Market Restraints
1.5.3 Immune Drugs Industry Trends
1.5.4 Immune Drugs Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Immune Drugs, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Immune Drugs, Global Market Share by Company, 2019-2024
2.3 Immune Drugs Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Immune Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Immune Drugs Concentration Ratio
2.6 Global Immune Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Immune Drugs Manufacturers Product Type
2.8 Head Office and Immune Drugs Production Site of Key Manufacturer
2.9 Immune Drugs Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Immune Drugs, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Immune Drugs, China Market Share by Company, 2019-2024
3.3 China Immune Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Immune Drugs Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Immune Drugs Capacity by Region
4.3 Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Immune Drugs Production by Region, 2019-2030
4.5 Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis
5.1 Immune Drugs Industry Chain
5.2 Immune Drugs Upstream Analysis
5.2.1 Immune Drugs Core Raw Materials
5.2.2 Main Manufacturers of Immune Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Immune Drugs Production Mode
5.6 Immune Drugs Procurement Model
5.7 Immune Drugs Industry Sales Model and Sales Channels
5.7.1 Immune Drugs Sales Model
5.7.2 Immune Drugs Typical Distributors

6 Sights by Type
6.1 Immune Drugs Classification
6.1.1 Immune Boosting Drugs
6.1.2 Immunosuppressant Drugs
6.2 By Type, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Immune Drugs Consumption Value, 2019-2030
6.4 By Type, Global Immune Drugs Sales Quantity, 2019-2030
6.5 By Type, Global Immune Drugs Average Selling Price (ASP), 2019-2030

7 Sights by Application
7.1 Immune Drugs Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Surgery Center
7.1.4 Others
7.2 By Application, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Immune Drugs Consumption Value, 2019-2030
7.4 By Application, Global Immune Drugs Sales Quantity, 2019-2030
7.5 By Application, Global Immune Drugs Price, 2019-2030

8 Sales Sights by Region
8.1 By Region, Global Immune Drugs Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Immune Drugs Consumption Value, 2019-2030
8.3 By Region, Global Immune Drugs Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Immune Drugs & Forecasts, 2019-2030
8.4.2 By Country, North America Immune Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Immune Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Immune Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Immune Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Immune Drugs Market Size Market Share
8.7 South America
8.7.1 South America Immune Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Immune Drugs Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Immune Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Immune Drugs Consumption Value, 2019-2030
9.3 By Country, Global Immune Drugs Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Immune Drugs Market Size, 2019-2030
9.4.2 By Type, U.S. Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.4.3 By Application, U.S. Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.5 Europe
9.5.1 Europe Immune Drugs Market Size, 2019-2030
9.5.2 By Type, Europe Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.5.3 By Application, Europe Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.6 China
9.6.1 China Immune Drugs Market Size, 2019-2030
9.6.2 By Type, China Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.6.3 By Application, China Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Immune Drugs Market Size, 2019-2030
9.7.2 By Type, Japan Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.7.3 By Application, Japan Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Immune Drugs Market Size, 2019-2030
9.8.2 By Type, South Korea Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.8.3 By Application, South Korea Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Immune Drugs Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.9.3 By Application, Southeast Asia Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.10 India
9.10.1 India Immune Drugs Market Size, 2019-2030
9.10.2 By Type, India Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.10.3 By Application, India Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.11 Middle East & Africa
9.11.1 Middle East & Africa Immune Drugs Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2024 VS 2030
9.11.3 By Application, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2024 VS 2030

10 Manufacturers Profile
10.1 Antares Pharma, Inc.
10.1.1 Antares Pharma, Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Antares Pharma, Inc. Immune Drugs Models, Specifications, and Application
10.1.3 Antares Pharma, Inc. Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Antares Pharma, Inc. Company Profile and Main Business
10.1.5 Antares Pharma, Inc. Recent Developments
10.2 UCB
10.2.1 UCB Company Information, Head Office, Market Area, and Industry Position
10.2.2 UCB Immune Drugs Models, Specifications, and Application
10.2.3 UCB Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 UCB Company Profile and Main Business
10.2.5 UCB Recent Developments
10.3 Incyte
10.3.1 Incyte Company Information, Head Office, Market Area, and Industry Position
10.3.2 Incyte Immune Drugs Models, Specifications, and Application
10.3.3 Incyte Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Incyte Company Profile and Main Business
10.3.5 Incyte Recent Developments
10.4 GSK
10.4.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.4.2 GSK Immune Drugs Models, Specifications, and Application
10.4.3 GSK Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 GSK Company Profile and Main Business
10.4.5 GSK Recent Developments
10.5 Takeda
10.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position
10.5.2 Takeda Immune Drugs Models, Specifications, and Application
10.5.3 Takeda Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Takeda Company Profile and Main Business
10.5.5 Takeda Recent Developments
10.6 3S Bio
10.6.1 3S Bio Company Information, Head Office, Market Area, and Industry Position
10.6.2 3S Bio Immune Drugs Models, Specifications, and Application
10.6.3 3S Bio Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 3S Bio Company Profile and Main Business
10.6.5 3S Bio Recent Developments
10.7 Horizon Therapeutics
10.7.1 Horizon Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.7.2 Horizon Therapeutics Immune Drugs Models, Specifications, and Application
10.7.3 Horizon Therapeutics Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Horizon Therapeutics Company Profile and Main Business
10.7.5 Horizon Therapeutics Recent Developments
10.8 Bristol-Myers Squibb (BMS
10.8.1 Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications, and Application
10.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Bristol-Myers Squibb (BMS Company Profile and Main Business
10.8.5 Bristol-Myers Squibb (BMS Recent Developments
10.9 Astellas
10.9.1 Astellas Company Information, Head Office, Market Area, and Industry Position
10.9.2 Astellas Immune Drugs Models, Specifications, and Application
10.9.3 Astellas Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Astellas Company Profile and Main Business
10.9.5 Astellas Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
10.10.2 Eli Lilly Immune Drugs Models, Specifications, and Application
10.10.3 Eli Lilly Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Eli Lilly Company Profile and Main Business
10.10.5 Eli Lilly Recent Developments
10.11 Mitsubishi Tanabe Pharma
10.11.1 Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications, and Application
10.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Mitsubishi Tanabe Pharma Company Profile and Main Business
10.11.5 Mitsubishi Tanabe Pharma Recent Developments
10.12 Biogen
10.12.1 Biogen Company Information, Head Office, Market Area, and Industry Position
10.12.2 Biogen Immune Drugs Models, Specifications, and Application
10.12.3 Biogen Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Biogen Company Profile and Main Business
10.12.5 Biogen Recent Developments
10.13 Pfizer
10.13.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.13.2 Pfizer Immune Drugs Models, Specifications, and Application
10.13.3 Pfizer Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Pfizer Company Profile and Main Business
10.13.5 Pfizer Recent Developments
10.14 Sanofi
10.14.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sanofi Immune Drugs Models, Specifications, and Application
10.14.3 Sanofi Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Sanofi Company Profile and Main Business
10.14.5 Sanofi Recent Developments
10.15 Roche
10.15.1 Roche Company Information, Head Office, Market Area, and Industry Position
10.15.2 Roche Immune Drugs Models, Specifications, and Application
10.15.3 Roche Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Roche Company Profile and Main Business
10.15.5 Roche Recent Developments
10.16 Novartis
10.16.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.16.2 Novartis Immune Drugs Models, Specifications, and Application
10.16.3 Novartis Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Novartis Company Profile and Main Business
10.16.5 Novartis Recent Developments
10.17 Johnson & Johnson (J&J)
10.17.1 Johnson & Johnson (J&J) Company Information, Head Office, Market Area, and Industry Position
10.17.2 Johnson & Johnson (J&J) Immune Drugs Models, Specifications, and Application
10.17.3 Johnson & Johnson (J&J) Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Johnson & Johnson (J&J) Company Profile and Main Business
10.17.5 Johnson & Johnson (J&J) Recent Developments
10.18 Amgen
10.18.1 Amgen Company Information, Head Office, Market Area, and Industry Position
10.18.2 Amgen Immune Drugs Models, Specifications, and Application
10.18.3 Amgen Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Amgen Company Profile and Main Business
10.18.5 Amgen Recent Developments
10.19 Abbvi
10.19.1 Abbvi Company Information, Head Office, Market Area, and Industry Position
10.19.2 Abbvi Immune Drugs Models, Specifications, and Application
10.19.3 Abbvi Immune Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.19.4 Abbvi Company Profile and Main Business
10.19.5 Abbvi Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
The Immune Drugs Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

Report Objectives / Segmentation Covered :

By Companies / players:
By Regions:
By Type:
By Application:

Frequently asked questions(FAQ's):

Is the Immune Drugs Global and China Top Players Market shifting its focus from growth to value?

Recognize the areas along the Immune Drugs Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.

What is the estimated value of the Immune Drugs Global and China Top Players Market?

The Immune Drugs Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.

Is further segmentation possible given the scope of the Immune Drugs Global and China Top Players Market study?

Yes, the add-on segmentation is available in the premium customised version of the Immune Drugs Global and China Top Players Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.

How does the Immune Drugs Global and China Top Players Market study reflects the current scenario?

The Immune Drugs Global and China Top Players study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.